Who Owns XTL BIOPHARMACEUTICALS-ADR (XTLB)? -- Institutional Holders (2026-06-30)

7 institutions reported holding $20,652 of XTL BIOPHARMACEUTICALS-ADR (XTLB) in SEC 13F filings for 2026-06-30. Largest institutional holders: RHUMBLINE ADVISERS ($17,000), GAMMA Investing LLC ($3,311), UBS Group AG ($341), Tower Research Capital LLC (TRC) ($0), Noked Israel Ltd ($0). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1RHUMBLINE ADVISERS$17,0006,228Added
2GAMMA Investing LLC$3,3111,213Trimmed
3UBS Group AG$341125New
4Tower Research Capital LLC (TRC)$00Exited
5Noked Israel Ltd$00Exited
6SmartHarvest Portfolios, LLC$00Exited
7MORGAN STANLEY$00Exited

Source: SEC Form 13F filings · as of 2026-06-30